P. Bianchini

发表

Binding, internalization and degradation of heparin and heparin fragments by cultured endothelial cells.

L. Magnelli, V. Chiarugi, S. Vannucchi, 1988, Thrombosis research.

Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities.

A. Al-Hakim, R. Linhardt, J. Fareed, 1991, Biochemical pharmacology.

PHARMACOLOGICAL PROPERTIES BY DEPOLYMERIZATION OF HEPARIN

P. Bianchini, 2017 .

Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions.

E. Dejana, G. Bazzoni, A. del Maschio, 1993, The Journal of laboratory and clinical medicine.

Pharmacokinetics of native and low molecular weight dermatans: preliminary studies in rats and primates.

D. Hoppensteadt, J. Fareed, J. Walenga, 1991, Seminars in thrombosis and hemostasis.

Heparin and non heparin ns future perspectives for future applications

P. Bianchini, 1994 .

Heparin and non-heparin glycosaminoglycans: future perspectives for future applications

P. Bianchini, 1994 .

Heterogeneity of heparin: characterization of one hundred components with different anticoagulant activities by a combination of electrophoretic and affinity chromatography methods

H. Nader, H. K. Takahashi, C. Dietrich, 1981 .

Heterogeneity of Unfractionated Heparins Studied in Connection with Species, Source, and Production Processes

L. Liverani, G. Mascellani, P. Bianchini, 1997, Seminars in thrombosis and hemostasis.

Characterization of di- and monosulfated, unsaturated heparin disaccharides with terminal N-sulfated 1,6-anhydro-beta-D-glucosamine or N-sulfated 1,6-anhydro-beta-D-mannosamine residues.

G. Torri, M. Guerrini, L. Liverani, 2007, Carbohydrate research.

Fractionation and identification of heparin and other acidic mucopolysaccharides by a new discontinuous electrophoretic method

H. Nader, H. K. Takahashi, A. H. Straus, 1980 .

Structural studies and "in vivo" and "in vitro" pharmacological activities of heparin fractions and fragments prepared by chemical and enzymic depolimerization.

H. Nader, H. K. Takahashi, C. Dietrich, 1985, Thrombosis research.

Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate.

G. Torri, B. Casu, M. Guerrini, 1993, The Biochemical journal.

Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.

L. Liverani, G. Mascellani, P. Bianchini, 1996, Thrombosis research.

Low molecular weight heparins (5 kDa) and oligoheparins (2 kDa) produced by gel permeation enrichment or radical process: comparison of structures and physicochemical and biological properties.

N. Volpi, G. Mascellani, P. Bianchini, 1992, Analytical biochemistry.

Molecular events involved in the proaggregating effect of heparin on human platelets.

M. Ruggiero, V. Chiarugi, S. Fedi, 1984, Biochimica et biophysica acta.

Reinvestigation of reductive butylation of aminophthalimides: new compounds with local anesthetic activity

G. Primofiore, A. D. Settimo, P. Ferrarini, 1989 .

Isolation of Endogenous Anticoagulant N-Sulfated Glycosaminoglycans in Human Plasma from Healthy Subjects

M. Ruggiero, S. Vannucchi, P. Bianchini, 2002, Pathophysiology of Haemostasis and Thrombosis.

Relationship between plasma antifactor Xa activity and the antithrombotic activity of heparins of different molecular mass.

P. Bianchini, B. Parma, G. Bergonzini, 1995, Haemostasis.

Relative influence of different disulphate disaccharide clusters on the HCII-mediated inhibition of thrombin by dermatan sulphates of different origins.

L. Liverani, G. Mascellani, P. Bianchini, 1994, Thrombosis research.

Rectal absorption of some glycosaminoglycan sulphates and heparin in rats

G. Corbelli, G. Mascellani, P. Bianchini, 1981, The Journal of pharmacy and pharmacology.

Immunological Safety Evaluation of a Horse Collagen Haemostatic Pad

P. Bianchini, B. Parma, 2001, Arzneimittelforschung.

Lack of correlation between "in vitro" and "in vivo" antithrombotic activity of heparin fractions and related compounds. Heparan sulfate as an antithrombotic agent "in vivo".

H. Nader, C. Dietrich, P. Bianchini, 1985, Thrombosis research.

Fractionation and structural features of two heparin families with high antithrombotic, antilipemic and anticoagulant activities.

H. Nader, G. Torri, C. Dietrich, 1985, Arzneimittel-Forschung.

Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.

H. Nader, C. Dietrich, P. Bianchini, 1982, The Journal of pharmacology and experimental therapeutics.

Isolation and pharmacological activities of heparin and other sulfated mucopolysaccharides from thymus.

H. Nader, A. H. Straus, P. Bianchini, 1981, Biochemical pharmacology.

Interaction of heparin and heparin fractions with human platelets.

M. Barbanti, P. Bianchini, L. Montecchi, 1982, Thrombosis research.

Dependence of the C-6 sulfate of the glucosamine moiety and 1----4 glycosidic linkage of heparin disaccharides for production of hemorrhage: reversal of the antihemostatic activity of heparin and their fragments by adenosine triphosphate and myosin.

H. Nader, C. Dietrich, I. Tersariol, 1991, Seminars in thrombosis and hemostasis.

A CONTRIBUTION TO THE PROBLEM OF HEPARIN

P. Bianchini, 1979 .

Biomarkers and Coagulation Tests for Assessing the Biosimilarity of a Generic Low‐Molecular‐Weight Heparin: Results of a Study in Healthy Subjects With Enoxaparin

Sebastian Harder, Bettina Picard-Willems, F. Donath, 2008, Journal of clinical pharmacology.

Active Sites of Dermatan Sulfate for Heparin Cofactor II. Isolation of a Nonasaccharide Fragment Containing Four Disaccharide Sequences [α-l-Iduronic Acid 2-O-Sulfate (1,3)-β-d-N-Acetylgalactosamine 4-Sulfate]

G. Torri, B. Casu, L. Silvestro, 1995 .

Effect of heparin derived fractions on the proliferation and protein synthesis of cells in culture.

R. Tiozzo, S. Calandra, P. Bianchini, 1991, Thrombosis research.

ACTION OF INDIA INK AND TRITON ON THE POST-HEPARINIC CLEARING FACTOR RELEASE.

P. Bianchini, 1964, Journal of Atherosclerosis Research.

Extraction Methods of Glycosaminoglycans from Biologic Fluids

G. Mascellani, P. Bianchini, B. Parma, 1994, Seminars in thrombosis and hemostasis.

Oligo-Heparin Action on Endogenous Glycosaminoglycans. Pharmacokinetics: Direct and Mediated Effects

L. Liverani, G. Mascellani, P. Bianchini, 1994, Seminars in thrombosis and hemostasis.